- Corporate Officers - L
- Loberg Michael D
Insider Trading History of Loberg Michael D
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Loberg Michael D since 2006.
This trader's CIK number is 1233414.
At the time of last reporting, Loberg Michael D was the Director of Igm Biosciences, Inc.. (stock ticker symbol IGMS).
Also see all insider trading activities at Igm Biosciences, Inc..
Note that in the past
LOBERG MICHAEL D also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Arqule Inc (ARQL) by Loberg Michael D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ARQL | 0 | $0 | 0 | $0 | 10,000 | $38,700 |
| 2015 | ARQL | 4,950 | $10,662 | 0 | $0 | 0 | $0 |
| 2011 | ARQL | 29,074 | $185,909 | 0 | $0 | 0 | $0 |
| 2009 | ARQL | 2,585 | $11,096 | 0 | $0 | 0 | $0 |
| 2008 | ARQL | 55,847 | $167,410 | 0 | $0 | 0 | $0 |
| 2007 | ARQL | 1,475 | $10,227 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Igm Biosciences, Inc. (IGMS) by Loberg Michael D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | IGMS | 34,239 | $753,748 | 0 | $0 | 0 | $0 |
| 2019 | IGMS | 5,000 | $92,865 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amag Pharmaceuticals, Inc. (AVM) by Loberg Michael D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | AVM | 0 | $0 | 63,000 | $1,521,292 | 63,000 | $358,942 |
Insider trading activities at 3 companies by Loberg Michael D:
1. Arqule Inc (ARQL)
2. Igm Biosciences, Inc. (IGMS)
3. Amag Pharmaceuticals, Inc. (AVM)
Table 1. Insider trading of Arqule Inc (ARQL) by Loberg Michael D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-10 | ARQL | Option Ex | 10,000 | 3.87 | 38,700 |
| 2015-12-17 | ARQL | Buy | 3,719 | 2.16 | 8,029 |
| 2015-12-16 | ARQL | Buy | 1,231 | 2.14 | 2,633 |
| 2011-06-07 | ARQL | Buy | 27,676 | 6.40 | 177,071 |
| 2011-05-25 | ARQL | Buy | 1,398 | 6.32 | 8,838 |
| 2009-08-18 | ARQL | Buy | 356 | 5.26 | 1,872 |
| 2009-08-13 | ARQL | Buy | 88 | 5.65 | 497 |
| 2009-07-24 | ARQL | Buy | 171 | 5.82 | 995 |
| 2009-05-18 | ARQL | Buy | 456 | 4.11 | 1,874 |
| 2009-05-14 | ARQL | Buy | 258 | 3.87 | 998 |
| 2009-04-09 | ARQL | Buy | 105 | 4.75 | 498 |
| 2009-03-12 | ARQL | Buy | 281 | 3.55 | 997 |
| 2009-02-18 | ARQL | Buy | 474 | 3.95 | 1,872 |
| 2009-02-12 | ARQL | Buy | 114 | 4.35 | 495 |
| 2009-01-20 | ARQL | Buy | 282 | 3.54 | 998 |
| 2008-12-16 | ARQL | Buy | 128 | 3.88 | 496 |
| 2008-11-24 | ARQL | Buy | 162 | 3.08 | 498 |
| 2008-11-17 | ARQL | Buy | 39,480 | 2.95 | 116,387 |
| 2008-11-13 | ARQL | Buy | 9,710 | 2.87 | 27,848 |
| 2008-11-14 | ARQL | Buy | 1,800 | 2.84 | 5,106 |
| 2008-10-27 | ARQL | Buy | 526 | 1.90 | 999 |
| 2008-10-09 | ARQL | Buy | 222 | 2.25 | 499 |
| 2008-09-12 | ARQL | Buy | 579 | 3.45 | 1,997 |
| 2008-08-18 | ARQL | Buy | 523 | 3.58 | 1,872 |
| 2008-08-07 | ARQL | Buy | 143 | 3.49 | 499 |
| 2008-07-17 | ARQL | Buy | 251 | 3.98 | 998 |
| 2008-07-11 | ARQL | Buy | 132 | 3.78 | 498 |
| 2008-06-05 | ARQL | Buy | 114 | 4.35 | 495 |
| 2008-05-29 | ARQL | Buy | 456 | 4.11 | 1,874 |
| 2008-05-15 | ARQL | Buy | 243 | 4.10 | 996 |
| 2008-05-07 | ARQL | Buy | 134 | 3.72 | 498 |
| 2008-04-10 | ARQL | Buy | 128 | 3.88 | 496 |
| 2008-03-25 | ARQL | Buy | 240 | 4.15 | 996 |
| 2008-03-21 | ARQL | Buy | 123 | 4.04 | 496 |
| 2008-02-15 | ARQL | Buy | 362 | 5.17 | 1,871 |
| 2008-02-14 | ARQL | Buy | 95 | 5.24 | 497 |
| 2008-01-17 | ARQL | Buy | 210 | 4.75 | 997 |
| 2008-01-03 | ARQL | Buy | 86 | 5.78 | 497 |
| 2007-12-20 | ARQL | Buy | 252 | 5.95 | 1,499 |
| 2007-11-13 | ARQL | Buy | 405 | 7.08 | 2,867 |
| 2007-11-01 | ARQL | Buy | 66 | 7.55 | 498 |
| 2007-10-25 | ARQL | Buy | 64 | 7.80 | 499 |
| 2007-10-04 | ARQL | Buy | 132 | 7.56 | 997 |
| 2007-09-18 | ARQL | Buy | 261 | 7.64 | 1,994 |
| 2007-08-17 | ARQL | Buy | 295 | 6.35 | 1,873 |
Table 2. Insider trading of Igm Biosciences, Inc. (IGMS) by Loberg Michael D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-09-29 | IGMS | Buy | 5,821 | 19.62 | 114,213 |
| 2022-09-27 | IGMS | Buy | 507 | 19.99 | 10,136 |
| 2022-09-28 | IGMS | Buy | 6,172 | 20.97 | 129,402 |
| 2022-04-01 | IGMS | Buy | 21,739 | 23.00 | 499,997 |
| 2019-09-18 | IGMS | Buy | 5,000 | 18.57 | 92,865 |
Table 3. Insider trading of Amag Pharmaceuticals, Inc. (AVM) by Loberg Michael D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-06-07 | AVM | Option Ex | 31,500 | 6.83 | 214,987 |
| 2006-06-05 | AVM | Sale | 8,000 | 24.02 | 192,120 |
| 2006-06-08 | AVM | Option Ex | 31,500 | 4.57 | 143,955 |
| 2006-06-07 | AVM | Sale | 31,500 | 24.28 | 764,820 |
| 2006-06-08 | AVM | Sale | 23,500 | 24.02 | 564,352 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Loberg Michael D
(Director of Igm Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.